Stage IVB Rectal Cancer Completed Phase 1 Trials for Binimetinib (DB11967)

IndicationStatusPhase
DBCOND0028589 (Stage IVB Rectal Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02041481MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal CancerTreatment